Français
2. Fate of nanomedicines after intravenous administration
2.1 Pharmacokinetics of nanoparticles
After blood administration, nanoparticles circulate in the circulatory torrent. To reach the tissues, these carriers will have to pass through arteries and then smaller-diameter arterioles. Thus, a dose of nanoparticles administered into a vein will reach the heart via the vena cava, then necessarily pass through the lungs to return to the heart via the pulmonary vein and rejoin the arterial circulation via the aorta (figure 2 ). Passage through the lungs is not a problem for small...
The Ultimate Scientific and Technical Reference
This article is included in
Healthcare technologies
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Fate of nanomedicines after intravenous administration
Fate after oral administration
Bibliography
Websites
European technology platform on nanomedicine: ETP – Nanomedicine. http://www.etp-nanomedicine.eu/public
The Ultimate Scientific and Technical Reference
